{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-002110","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2025-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.111197+00:00","generated_at":"2026-05-23T18:20:57.679377+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Corvus Pharmaceuticals appoints Richard van den Broek to Board, effective April 8, 2025","bullets":["Richard van den Broek appointed as Class II director, term expiring at 2027 annual meeting.","Appointed to Audit Committee ($10k annual) and Nominating Committee ($4k annual) effective April 8, 2025.","Will receive $35k annual board retainer, prorated for current quarter, plus initial option for 30,000 shares.","Will enter into standard indemnification agreement for directors and officers.","Compensation consistent with company's non-employee director compensation program."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-002110","json":"https://secwatch.observer/filing/0001171843-25-002110.json","markdown":"https://secwatch.observer/filing/0001171843-25-002110.md","text":"https://secwatch.observer/filing/0001171843-25-002110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000117184325002110/0001171843-25-002110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000117184325002110/f8k_040825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T18:20:57.679377+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"790d0726b7","claim":"Richard van den Broek was appointed as Director at Corvus Pharmaceuticals, Inc..","evidence_excerpt":"appointed Richard van den Broek to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626971/000117184325002110/0001171843-25-002110-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}